Why the study?
Is there a difference in efficacy and safety between danaparoid, enoxaparin, and dalteparin for thromboprophylaxis in patients undergoing hip fracture surgery?
Population
197 patients with hip fracture undergoing surgery
Comparison
Danaparoid, enoxaparin, or dalteparin given for… vs Active comparators
Design
RCT, randomised, assessor-blind
Follow-up
9-11 days
Loading...
Comparable safety/efficacy supports clinical equipoise among agents; pilot RCT leaves open larger definitive trials.
Is there a difference in efficacy and safety between danaparoid, enoxaparin, and dalteparin for thromboprophylaxis in patients undergoing hip fracture surgery?
In a pilot study of patients undergoing hip fracture surgery, danaparoid, enoxaparin, and dalteparin showed similar efficacy and safety for thromboprophylaxis.
A 1999 study studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: